A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy

Exclusion Criteria

• •diagnosis or history of type 1 diabetes mellitus or secondary forms of diabetes
• •acute metabolic diabetic complications or evidence of clinically significant diabetic complications
• •clinically symptomatic gastrointestinal disease
• •history of chronic pancreatitis or acute idiopathic pancreatitis
• •\>3 episodes of severe hypoglycemia within 6 months prior to screening
• •miocardial infarcion, unstable angina pectoris, coronary artery bypass surgery, post-transplantation cardiomyopathy or stroke within 6 months prior to screening
• •any treatment with exenatide, exendin analogues, GLP-1 or its analogues